CN105558059A - Formula goat milk powder for infants and preparation method thereof - Google Patents
Formula goat milk powder for infants and preparation method thereof Download PDFInfo
- Publication number
- CN105558059A CN105558059A CN201510944240.1A CN201510944240A CN105558059A CN 105558059 A CN105558059 A CN 105558059A CN 201510944240 A CN201510944240 A CN 201510944240A CN 105558059 A CN105558059 A CN 105558059A
- Authority
- CN
- China
- Prior art keywords
- milk powder
- goat milk
- batching
- sterilization
- infant formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000843 powder Substances 0.000 title claims abstract description 60
- 235000020251 goat milk Nutrition 0.000 title claims abstract description 57
- 238000002360 preparation method Methods 0.000 title claims abstract description 14
- 239000006041 probiotic Substances 0.000 claims abstract description 23
- 235000018291 probiotics Nutrition 0.000 claims abstract description 23
- 150000001875 compounds Chemical class 0.000 claims abstract description 22
- 150000002270 gangliosides Chemical class 0.000 claims abstract description 19
- 239000002994 raw material Substances 0.000 claims abstract description 13
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 claims abstract description 12
- 238000000034 method Methods 0.000 claims abstract description 11
- 235000015112 vegetable and seed oil Nutrition 0.000 claims abstract description 11
- 239000008158 vegetable oil Substances 0.000 claims abstract description 11
- 239000004519 grease Substances 0.000 claims abstract description 10
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims abstract description 8
- 235000019742 Vitamins premix Nutrition 0.000 claims abstract description 8
- 102000007544 Whey Proteins Human genes 0.000 claims abstract description 8
- 108010046377 Whey Proteins Proteins 0.000 claims abstract description 8
- 239000008101 lactose Substances 0.000 claims abstract description 8
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims abstract description 8
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract description 7
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 claims abstract description 7
- 239000008103 glucose Substances 0.000 claims abstract description 7
- 239000007787 solid Substances 0.000 claims abstract description 7
- 239000000126 substance Substances 0.000 claims abstract description 7
- 239000006188 syrup Substances 0.000 claims abstract description 7
- 235000020357 syrup Nutrition 0.000 claims abstract description 7
- 229940114079 arachidonic acid Drugs 0.000 claims abstract description 6
- 235000021342 arachidonic acid Nutrition 0.000 claims abstract description 6
- 235000020669 docosahexaenoic acid Nutrition 0.000 claims abstract description 5
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 5
- 239000011707 mineral Substances 0.000 claims abstract description 5
- 229960003080 taurine Drugs 0.000 claims abstract description 4
- 235000013350 formula milk Nutrition 0.000 claims description 45
- 230000001954 sterilising effect Effects 0.000 claims description 42
- 238000004659 sterilization and disinfection Methods 0.000 claims description 32
- 230000000529 probiotic effect Effects 0.000 claims description 20
- 239000000463 material Substances 0.000 claims description 12
- 240000001046 Lactobacillus acidophilus Species 0.000 claims description 10
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 claims description 10
- 229940039695 lactobacillus acidophilus Drugs 0.000 claims description 10
- 241000186000 Bifidobacterium Species 0.000 claims description 9
- 230000008569 process Effects 0.000 claims description 9
- 241001465754 Metazoa Species 0.000 claims description 8
- 241001494479 Pecora Species 0.000 claims description 8
- 238000000265 homogenisation Methods 0.000 claims description 8
- 239000005862 Whey Substances 0.000 claims description 7
- 238000005238 degreasing Methods 0.000 claims description 7
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 6
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 6
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 6
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 claims description 6
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 6
- RMRCNWBMXRMIRW-BYFNXCQMSA-M cyanocobalamin Chemical compound N#C[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O RMRCNWBMXRMIRW-BYFNXCQMSA-M 0.000 claims description 6
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 6
- 238000003860 storage Methods 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- SBJKKFFYIZUCET-JLAZNSOCSA-N Dehydro-L-ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(=O)C1=O SBJKKFFYIZUCET-JLAZNSOCSA-N 0.000 claims description 5
- 239000012141 concentrate Substances 0.000 claims description 5
- 230000000694 effects Effects 0.000 claims description 5
- 235000008504 concentrate Nutrition 0.000 claims description 4
- 239000006071 cream Substances 0.000 claims description 4
- 235000010755 mineral Nutrition 0.000 claims description 4
- 239000001763 2-hydroxyethyl(trimethyl)azanium Substances 0.000 claims description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 3
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims description 3
- 235000019743 Choline chloride Nutrition 0.000 claims description 3
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 3
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims description 3
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims description 3
- 235000019486 Sunflower oil Nutrition 0.000 claims description 3
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims description 3
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 3
- 229960005070 ascorbic acid Drugs 0.000 claims description 3
- 235000010323 ascorbic acid Nutrition 0.000 claims description 3
- 239000011668 ascorbic acid Substances 0.000 claims description 3
- 229960002685 biotin Drugs 0.000 claims description 3
- 235000020958 biotin Nutrition 0.000 claims description 3
- 239000011616 biotin Substances 0.000 claims description 3
- 239000011575 calcium Substances 0.000 claims description 3
- 229960005069 calcium Drugs 0.000 claims description 3
- 229910052791 calcium Inorganic materials 0.000 claims description 3
- 235000001465 calcium Nutrition 0.000 claims description 3
- 229910000019 calcium carbonate Inorganic materials 0.000 claims description 3
- 239000001110 calcium chloride Substances 0.000 claims description 3
- 229910001628 calcium chloride Inorganic materials 0.000 claims description 3
- 235000011148 calcium chloride Nutrition 0.000 claims description 3
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 claims description 3
- SGMZJAMFUVOLNK-UHFFFAOYSA-M choline chloride Chemical compound [Cl-].C[N+](C)(C)CCO SGMZJAMFUVOLNK-UHFFFAOYSA-M 0.000 claims description 3
- 229960003178 choline chloride Drugs 0.000 claims description 3
- 239000003240 coconut oil Substances 0.000 claims description 3
- 235000019864 coconut oil Nutrition 0.000 claims description 3
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 claims description 3
- 229960002104 cyanocobalamin Drugs 0.000 claims description 3
- 235000000639 cyanocobalamin Nutrition 0.000 claims description 3
- 239000011666 cyanocobalamin Substances 0.000 claims description 3
- 235000019700 dicalcium phosphate Nutrition 0.000 claims description 3
- BVTBRVFYZUCAKH-UHFFFAOYSA-L disodium selenite Chemical group [Na+].[Na+].[O-][Se]([O-])=O BVTBRVFYZUCAKH-UHFFFAOYSA-L 0.000 claims description 3
- CEYULKASIQJZGP-UHFFFAOYSA-L disodium;2-(carboxymethyl)-2-hydroxybutanedioate Chemical compound [Na+].[Na+].[O-]C(=O)CC(O)(C(=O)O)CC([O-])=O CEYULKASIQJZGP-UHFFFAOYSA-L 0.000 claims description 3
- 239000011790 ferrous sulphate Substances 0.000 claims description 3
- 235000003891 ferrous sulphate Nutrition 0.000 claims description 3
- 229960000304 folic acid Drugs 0.000 claims description 3
- 235000019152 folic acid Nutrition 0.000 claims description 3
- 239000011724 folic acid Substances 0.000 claims description 3
- 235000021255 galacto-oligosaccharides Nutrition 0.000 claims description 3
- 150000003271 galactooligosaccharides Chemical class 0.000 claims description 3
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical group O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 claims description 3
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 claims description 3
- 229910000359 iron(II) sulfate Inorganic materials 0.000 claims description 3
- 229910001629 magnesium chloride Inorganic materials 0.000 claims description 3
- 235000011147 magnesium chloride Nutrition 0.000 claims description 3
- 229940099596 manganese sulfate Drugs 0.000 claims description 3
- 239000011702 manganese sulphate Substances 0.000 claims description 3
- 235000007079 manganese sulphate Nutrition 0.000 claims description 3
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 229960003966 nicotinamide Drugs 0.000 claims description 3
- 235000005152 nicotinamide Nutrition 0.000 claims description 3
- 239000011570 nicotinamide Substances 0.000 claims description 3
- 239000002773 nucleotide Substances 0.000 claims description 3
- 125000003729 nucleotide group Chemical group 0.000 claims description 3
- -1 phytondione Chemical compound 0.000 claims description 3
- 239000001508 potassium citrate Substances 0.000 claims description 3
- 229960002635 potassium citrate Drugs 0.000 claims description 3
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 claims description 3
- 235000011082 potassium citrates Nutrition 0.000 claims description 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Substances [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 claims description 3
- 229960002477 riboflavin Drugs 0.000 claims description 3
- 235000019192 riboflavin Nutrition 0.000 claims description 3
- 239000002151 riboflavin Substances 0.000 claims description 3
- 239000003549 soybean oil Substances 0.000 claims description 3
- 235000012424 soybean oil Nutrition 0.000 claims description 3
- 238000005507 spraying Methods 0.000 claims description 3
- 239000002600 sunflower oil Substances 0.000 claims description 3
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims description 3
- 229960000344 thiamine hydrochloride Drugs 0.000 claims description 3
- 235000019190 thiamine hydrochloride Nutrition 0.000 claims description 3
- 239000011747 thiamine hydrochloride Substances 0.000 claims description 3
- 229940042585 tocopherol acetate Drugs 0.000 claims description 3
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 claims description 3
- 235000005282 vitamin D3 Nutrition 0.000 claims description 3
- 239000011647 vitamin D3 Substances 0.000 claims description 3
- 229940021056 vitamin d3 Drugs 0.000 claims description 3
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 claims description 3
- 229960001763 zinc sulfate Drugs 0.000 claims description 3
- 229910000368 zinc sulfate Inorganic materials 0.000 claims description 3
- 235000020256 human milk Nutrition 0.000 abstract description 25
- 210000004251 human milk Anatomy 0.000 abstract description 25
- 210000004556 brain Anatomy 0.000 abstract description 13
- 230000004641 brain development Effects 0.000 abstract description 6
- 238000011031 large-scale manufacturing process Methods 0.000 abstract description 2
- 229940090949 docosahexaenoic acid Drugs 0.000 abstract 2
- 235000021243 milk fat Nutrition 0.000 abstract 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 abstract 1
- 241000283707 Capra Species 0.000 abstract 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 abstract 1
- 230000002195 synergetic effect Effects 0.000 abstract 1
- 230000001228 trophic effect Effects 0.000 abstract 1
- 235000021119 whey protein Nutrition 0.000 abstract 1
- 238000012360 testing method Methods 0.000 description 23
- 235000016709 nutrition Nutrition 0.000 description 11
- 238000011160 research Methods 0.000 description 11
- 230000012010 growth Effects 0.000 description 10
- 238000011161 development Methods 0.000 description 8
- 230000018109 developmental process Effects 0.000 description 8
- 239000000203 mixture Substances 0.000 description 8
- 235000013336 milk Nutrition 0.000 description 7
- 239000008267 milk Substances 0.000 description 7
- 210000004080 milk Anatomy 0.000 description 7
- 238000002372 labelling Methods 0.000 description 6
- 210000004958 brain cell Anatomy 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 230000035764 nutrition Effects 0.000 description 5
- 235000018102 proteins Nutrition 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 206010012735 Diarrhoea Diseases 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- 210000005036 nerve Anatomy 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 3
- 230000003044 adaptive effect Effects 0.000 description 3
- 230000000172 allergic effect Effects 0.000 description 3
- 208000010668 atopic eczema Diseases 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 235000013365 dairy product Nutrition 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 230000011273 social behavior Effects 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 206010010774 Constipation Diseases 0.000 description 2
- 108060003951 Immunoglobulin Proteins 0.000 description 2
- 230000035606 childbirth Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 230000003862 health status Effects 0.000 description 2
- 102000018358 immunoglobulin Human genes 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 230000008774 maternal effect Effects 0.000 description 2
- 230000003340 mental effect Effects 0.000 description 2
- 230000001537 neural effect Effects 0.000 description 2
- 230000036417 physical growth Effects 0.000 description 2
- 230000000241 respiratory effect Effects 0.000 description 2
- PXFBZOLANLWPMH-UHFFFAOYSA-N 16-Epiaffinine Natural products C1C(C2=CC=CC=C2N2)=C2C(=O)CC2C(=CC)CN(C)C1C2CO PXFBZOLANLWPMH-UHFFFAOYSA-N 0.000 description 1
- 102000009366 Alpha-s1 casein Human genes 0.000 description 1
- 108050000244 Alpha-s1 casein Proteins 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 102000004407 Lactalbumin Human genes 0.000 description 1
- 108090000942 Lactalbumin Proteins 0.000 description 1
- 102000010445 Lactoferrin Human genes 0.000 description 1
- 108010063045 Lactoferrin Proteins 0.000 description 1
- 206010027336 Menstruation delayed Diseases 0.000 description 1
- 208000009793 Milk Hypersensitivity Diseases 0.000 description 1
- 201000010859 Milk allergy Diseases 0.000 description 1
- 208000036071 Rhinorrhea Diseases 0.000 description 1
- 206010039101 Rhinorrhoea Diseases 0.000 description 1
- 206010000059 abdominal discomfort Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 230000002009 allergenic effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 description 1
- 229940078795 lactoferrin Drugs 0.000 description 1
- 235000021242 lactoferrin Nutrition 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 230000008054 signal transmission Effects 0.000 description 1
- 238000004088 simulation Methods 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/16—Agglomerating or granulating milk powder; Making instant milk powder; Products obtained thereby
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
- A23C9/1522—Inorganic additives, e.g. minerals, trace elements; Chlorination or fluoridation of milk; Organic salts or complexes of metals other than natrium or kalium; Calcium enrichment of milk
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
- A23C9/1526—Amino acids; Peptides; Protein hydrolysates; Nucleic acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
- A23C9/1528—Fatty acids; Mono- or diglycerides; Petroleum jelly; Paraffine; Phospholipids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
- A23C9/158—Milk preparations; Milk powder or milk powder preparations containing additives containing vitamins or antibiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/113—Acidophilus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/515—Animalis
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Inorganic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nutrition Science (AREA)
- Biophysics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dairy Products (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention firstly aims at providing formula goat milk powder for infants. The formula goat milk powder for the infants is prepared from the following raw materials in parts by weight: degreased goat milk powder, whole goat milk powder, concentrated goat whey protein powder, gangliosides, lactose, glucose syrup solids, milk fat, OPO structure grease, docosahexaenoic acid, arachidonic acid, a vitamin premix, a mineral substance premix, taurine, vegetable oil, compound probiotics and the like. According to the formula goat milk powder for the infants, provided by the invention, brain trophic factors including the gangliosides, the milk fat, the OPO structure grease and the compound probiotics and the like are added; particularly, the synergistic effect of the gangliosides, the docosahexaenoic acid and the arachidonic acid is utilized so that functional components of the formula goat milk powder for the infants are relatively close to those of breast milk; and furthermore, the brain development of the infants is further improved. The invention secondly aims at providing a preparation method of the formula goat milk powder for the infants, and the preparation method has the characteristics of simple process steps and easiness of controlling technical parameters, and is suitable for large-scale production.
Description
Technical field
The present invention relates to field of food, be specifically related to a kind of infant formula goat milk powder and preparation method thereof.
Background technology
Breast milk is that nutrition first-selected in infant growth process is the most complete, safest natural food, but causes breastfeeding rate only about 35% due to some cause specifics, and therefore, dispensed food for baby is the important source of nutrition of infant.
Female composition of milk mainly can be divided into two large classes, and one is trophism composition, and trophism composition mainly refers to as people's body provides energy, such as lactose, fat and protein; Two is functional components, and functional components refers to the composition regulating human immunologic function, participate in the reparation that some is organized, such as immunoglobulin (Ig), lactoferrin, compound sugar, gangliosides etc.Present stage dispensed food for baby simulation breast milk research on mainly concentrate on protein, fat structure composition be tending towards breast milk, the research for functional components breast milk is then relatively less.
Goat milk is a kind of nutrition food completely, grow containing human growth can be promoted and maintain healthy required nutritional labeling, the ratio of various nutritional labeling contained by it, be applicable to the needs that grow of infant, the dairy products of the current nutritional labeling found closest to breast milk, in addition, in goat milk, in the composition of protein and milk, the composition of protein has notable difference, containing a large amount of lactalbumins and immunoglobulin (Ig) in goat milk, and α-S1 casein content is far below milk, so, goat milk can not cause has a stomach upset, diarrhoea waits dairy products allergic symptom to occur, the dairy products that the people of any physique can accept, especially be applicable to milk allergy and the more weak crowd of physique.
The brain development of human body mainly concentrates on fetus and infant period, and newborn baby's brain weight only has 350-400 gram, be approximately 25% of adult's brain weight, and the growth of brain will reach 80% of adult's size 3 years old time.The g and D of brain runs through whole infant period, and the different piece of brain grows with ripe with different speed.Pregnancy period and infantile period are the periods of brain ramp and growth, mainly because neuron produces bifurcated in this period and is connected to form network structure, thus establish the basis of learning and memory.In the critical period that brain is grown rapidly, higher demand is have to support the growth of brain structure and function to nutrition.
In sum, a kind of applicable infants is badly in need of and the milk powder that brain development is had very great help in industry.
Summary of the invention
The first object of the present invention is to provide a kind of applicable infants and formula milk brain development to facilitation, and concrete technical scheme is as follows:
A kind of infant formula goat milk powder, comprises following component with weight parts raw material:
Compound probiotic 2.0 × 10
7cfu/g-3.0 × 10
7cfu/g.
Preferred in above technical scheme, described compound probiotic is made up of the animal bifidobacteria of 1:0.5-1.5 weight proportion and lactobacillus acidophilus.
Preferred in above technical scheme, described vegetable oil by weight proportion be the coconut oil of 3:2:1, soybean oil and sunflower oil form; Ascorbic acid, dl-α-D-α-tocopherol acetate, niacinamide, D-VB5 calcium, riboflavin, thiamine hydrochloride, puridoxine hydrochloride, axerophtholum aceticum, folic acid, phytondione, biotin, Vitamin D3, cyanocobalamin, Choline Chloride and inositol that described vitamin premix is 65:7:5:2.4:1:0.7:0.65:0.53:0.78:0.04:0.02:0.01:0.01:6.65: 37.2 by weight proportion form; Described material premix by weight proportion be the calcium carbonate of 33:15:16:11:5:3.2:0.4:0.25:0.04:0.015:0.009:0.001, natrium citricum, calcium monohydrogen phosphate, calcium chloride, potassium citrate, magnesium chloride, ferrous sulfate, zinc sulfate, copper sulphate, manganese sulfate, KI and sodium selenite form.
The signal transmission of brain is undertaken by the connection between brain cell and brain cell.In brain cell network, the change of the growth that new brain cell connects and bonding strength is considered to remember the basis formed.Gangliosides are keys of neural linkage function, and the growth of brain is relevant with the increase of gangliosides with maturation.Neonate has 1,000 hundred million nerves not having to connect, and when environment changes (as environmental stimulus excites with mother), increasing nerve can be connected, and in the key period, nerve at a high speed connects generation and needs a large amount of gangliosides.Nerve is connected with and helps information transmission, thus strengthens study idea and memory; Gangliosides also act on the neural constituent connecting two ends simultaneously, make the signal of telecommunication between brain cell can convert chemical signal to from one end, then go back to into the signal of telecommunication from the other end, guarantee that connection is ready.Research shows, pregnant late period was that gangliosides and DHA accumulate period rapidly in the brain by 3 years old, therefore, added gangliosides significant in baby milk powder.
Infant formula goat milk powder of the present invention has following effect:
(1) with the addition of brain nutrition factor gangliosides in the present invention's formula, particularly utilize the synergy of gangliosides, DHA and arachidonic acid three, make formula milk on functional component composition closer to breast milk, the brain development (being especially embodied in intelligence development aspect, specifically: the mark convergence breast milk group or identical with breast milk group showed with Social behaviors, hand eye coordination, big-movement, adaptive capacity and operation at fine movement, language) of further promotion infant.
(2) with the addition of special construction grease OPO in the present invention's formula, the promotion infant utilizing OPO Structure grease to have, to the function of the absorption of nutritional labeling, reduces the probability of getting angry and occurring with constipation, contributes to growing of infant; Add the butterfat of fat content about 40% simultaneously, utilize the molecular structure of butterfat closer to the advantage in body fat acid site, only adopt the more affine enteron aisle of the milk powder of vegetable oil than other, improve the absorptivity of other nutritional labelings.
(3) adopt degreasing goat milk powder, full-cream goat milk powder and concentrated sheep PURE WHEY in the present invention's formula, the caseic content of allergenic protein α-S1 is very low, promotes the absorption of nutriment while reducing the irritated incidence of infant.
(4) compound probiotic be made up of according to special proportioning animal bifidobacteria and lactobacillus acidophilus is adopted in the present invention's formula, can effectively strengthen enteron aisle vigor, reduce risk of diarrhoea, lactobacillus acidophilus can secrete antibiotic agents, thus suppresses the propagation of enteron aisle undesirable microorganism; And two kinds of probios are added and have certain synergy simultaneously, specifically: lactobacillus acidophilus can produce the material of other growth of probiotics such as releasing beneficial Bifidobacterium in enteron aisle, thus increase the probio quantity in enteron aisle, strengthen activity of probiotic;
The nutriment such as vitamin premix, mineral substance premix adds and makes nutritional labeling contained by infant formula goat milk powder further close to breast milk.
The present invention second object is the preparation method providing a kind of above-mentioned infant formula goat milk powder, comprises the following steps:
Step one: premixed, be specially: the degreasing goat milk powder of predetermined weight proportioning, concentrated sheep PURE WHEY, vegetable oil, OPO Structure grease, glucose syrup solids, lactose and water are mixed and obtains the first batching, put into temporary storage tank to keep in, temporary storage time is no more than 12 hours, and wherein the weight of water is degreasing goat milk powder, concentrates 2.0-4.0 times of sheep PURE WHEY, vegetable oil, OPO Structure grease, glucose syrup solids and lactose six kinds of material gross weights;
Step 2: homogeneous for the first time, is specially: the first batching step one obtained is carried out homogeneous and obtained the second batching in high pressure homogenizer, and homogenization pressure is 12-18Mpa;
Step 3: first time sterilization, is specially: prepared burden by step 2 gained second and carry out sterilization in tubular type sterilizer, sterilization temperature is 90-100 DEG C, and sterilizing time is 1-2min;
Step 4: concentrated, is specially: being prepared burden by second after step 3 sterilization to carry out concentrating in triple effect evaporator obtains the 3rd batching;
Step 5: second time sterilization, is specially: the 3rd batching is carried out sterilization in tubular type sterilizer, and sterilization temperature is 70-75 DEG C, and sterilizing time is 1-5min;
Step 6: second time homogeneous, is specially: the 3rd batching after step 5 sterilization is carried out homogeneous in homogenizer and obtains the 4th batching, homogenization pressure is 12-18Mpa;
Step 7: dry, is specially: the spray-dried tower of the 4th batching is carried out spraying dry, obtains the 5th batching;
Step 8: be dry mixed, is specially: the full-cream goat milk powder of predetermined weight proportioning, FOS, galactooligosaccharide, DHA, arachidonic acid, vitamin premix, mineral substance premix, nucleotides, l-cn, butterfat and compound probiotic, taurine and gangliosides are added in the 5th batching and carry out mixing to obtain infant formula goat milk powder.
Preferred in above technical scheme, described first time homogenizing process and second time homogenizing process in homogenization pressure be 15Mpa;
In described first time sterilization process: sterilization temperature is 95 DEG C, and sterilizing time is 1min;
In described second time sterilization process: sterilization temperature is 72 DEG C, sterilizing time is 1min.
The inventive method has the features such as processing step is simplified, technological parameter easily controls, applicable large-scale production.
Except object described above, feature and advantage, the present invention also has other object, feature and advantage.Below with reference to specific embodiment, the present invention is further detailed explanation.
Detailed description of the invention
Below in conjunction with specific embodiment, embodiments of the invention are described in detail, but the multitude of different ways that the present invention can limit according to claim and cover is implemented.
Embodiment 1:
A kind of infant formula goat milk powder, comprises following component with weight parts raw material:
Compound probiotic 2.0 × 10
7cfu/g.
Described compound probiotic is made up of according to the quality proportioning of 1:0.5 animal bifidobacteria and lactobacillus acidophilus.
Described vegetable oil by weight proportion be the coconut oil of 3:2:1, soybean oil and sunflower oil form.
Described vitamin premix by weight proportion is: the ascorbic acid of 65:7:5:2.4:1:0.7:0.65:0.53:0.78:0.04:0.02:0.01:0.01:6.65: 37.2, dl-α-D-α-tocopherol acetate, niacinamide, D-VB5 calcium, riboflavin, thiamine hydrochloride, puridoxine hydrochloride, axerophtholum aceticum, folic acid, phytondione, biotin, Vitamin D3, cyanocobalamin, Choline Chloride and inositol form.
Described material premix by weight proportion be the calcium carbonate of 33:15:16:11:5:3.2:0.4:0.25:0.04:0.015:0.009:0.001, natrium citricum, calcium monohydrogen phosphate, calcium chloride, potassium citrate, magnesium chloride, ferrous sulfate, zinc sulfate, copper sulphate, manganese sulfate, KI and sodium selenite form.
The preparation method of above-mentioned infant formula goat milk powder, comprises the following steps:
Step one: premixed, be specially: the degreasing goat milk powder of predetermined weight proportioning, concentrated sheep PURE WHEY, vegetable oil, OPO Structure grease, glucose syrup solids, lactose and water are mixed and obtains the first batching, put into temporary storage tank to keep in, temporary storage time is no more than 12 hours, and wherein the weight of water is degreasing goat milk powder, concentrates 2.0 times of sheep PURE WHEY, vegetable oil, OPO Structure grease, glucose syrup solids and lactose six kinds of material gross weights;
Step 2: homogeneous for the first time, is specially: the first batching step one obtained is carried out homogeneous and obtained the second batching in high pressure homogenizer, and homogenization pressure is 15Mpa;
Step 3: first time sterilization, is specially: prepared burden by step 2 gained second and carry out sterilization in tubular type sterilizer, sterilization temperature is 95 DEG C, and sterilizing time is 2min;
Step 4: concentrated, is specially: being prepared burden by second after step 3 sterilization to carry out concentrating in triple effect evaporator obtains the 3rd batching;
Step 5: second time sterilization, is specially: the 3rd batching in step 4 is carried out sterilization in tubular type sterilizer, and sterilization temperature is 70 DEG C, and sterilizing time is 1min;
Step 6: second time homogeneous, is specially: the 3rd batching after step 5 sterilization is carried out homogeneous in homogenizer and obtains the 4th batching, homogenization pressure is 15Mpa;
Step 7: dry, is specially: the spray-dried tower of the 4th batching is carried out spraying dry, obtains the 5th batching;
Step 8: be dry mixed; be specially: the full-cream goat milk powder of predetermined weight proportioning, FOS, galactooligosaccharide, DHA, arachidonic acid, vitamin premix, mineral substance premix, nucleotides, l-cn, butterfat and compound probiotic, taurine and gangliosides are added in the 5th batching and carry out mixing and obtaining infant formula goat milk powder, be labeled as NF1.
The present embodiment infant formula goat milk powder can also adopt existing dry process to obtain.
The testing result of above-mentioned infant formula goat milk powder NF1 refers to table 1.
Embodiment 2:
A kind of infant formula goat milk powder, comprises following component with weight parts raw material:
Compound probiotic 3.0 × 10
7cfu/g.
Described compound probiotic is made up of according to the quality proportioning of 1:1.5 animal bifidobacteria and lactobacillus acidophilus.
Gained infant formula goat milk powder, with embodiment 1, is labeled as NF2 by its preparation method and other materials.
The testing result of above-mentioned infant formula goat milk powder NF2 refers to table 1.
Embodiment 3:
A kind of infant formula goat milk powder, comprises following component with weight parts raw material:
Compound probiotic 2.15 × 10
7cfu/g.
Described compound probiotic is made up of according to the quality proportioning of 1:1.0 animal bifidobacteria and lactobacillus acidophilus.
Gained infant formula goat milk powder, with embodiment 1, is labeled as NF3 by its preparation method and other materials.
The testing result of above-mentioned infant formula goat milk powder NF3 refers to table 1.
Embodiment 4:
A kind of infant formula goat milk powder, comprises following component with weight parts raw material:
Compound probiotic 2.4 × 10
7cfu/g.
Described compound probiotic is made up of according to the quality proportioning of 1:1.3 animal bifidobacteria and lactobacillus acidophilus.
Its preparation method and other materials are with embodiment 1, and its testing result is with embodiment 1.
Embodiment 5:
A kind of infant formula goat milk powder, comprises following component with weight parts raw material:
Compound probiotic 2.8 × 10
7cfu/g.
Described compound probiotic is made up of according to the quality proportioning of 1:0.9 animal bifidobacteria and lactobacillus acidophilus.
Its preparation method and other materials are with embodiment 1, and its testing result is with embodiment 3.
Comparative example:
A kind of infant formula goat milk powder, comprises following component with weight parts raw material:
This comparative example is not except containing except gangliosides, and its preparation method and its detection method are all with embodiment 1.
The testing result of above-mentioned infant formula goat milk powder DNF refers to table 1.
The testing result of table 1NF1-NF3 and DNF
In form 1, A represents: the milk yellow in uniformity, has milk fragrance; Dry, uniform powdered substance, nothing caking, without the alien material that twenty-twenty vision is visual; Lower sinker, reconstitute rear without agglomerate and precipitation.
The present embodiment 1-5, comparative example, regular convention formula milk powder (not adding gangliosides, OPO, butterfat and compound probiotic) and breast milk is adopted to carry out feeding trial respectively:
One: on physical growth of infants and the disease impact that a situation arises
1, inspection target: the growth rate of the body weight of infant, height and head circumference; The generation of allergic phenomena, respiratory symptom (cough, pharyngalgia, runny nose etc.) and diarrhoea situation incidence.
2, research object: select 210 infants as research object, research object is divided into seven groups at random:
Group 1 feeds regular convention formula milk powder, and as a control group 1;
Group 2-group 6 feeds baby's infant formula goat milk powder of embodiment 1-5, as test group 1-test group 5;
Organize 7 with breast-feeding, as breast milk group;
The nursing time is 3 months, research object age, sex, childbirth options, maternal age, the equilibrium of mother's health status equal distribution between each group, there was no significant difference (P>0.05).
3, result of the test:
Control group 1, test group 1-5 and breast milk group on physical growth of infants and the disease impact that a situation arises as table 2:
Table 2 control group 1, test group 1-5 and breast milk group affect statistical form to infants growth and development
As can be seen from Table 2, the baby of test group 1-5 and breast milk group in allergic phenomena incidence, respiratory symptom incidence, diarrhoea situation incidence, incidence of getting angry, constipation incidence significantly lower than control group 1, baby's unknown significance difference between other indexs of test group 1-5 and breast milk group.Result of the test illustrate in the present invention with pure sheep lactoprotein for raw material, with the addition of OPO, butterfat and compound probiotic formula milk powder, closer to breast milk, be conducive to the absorption of infant to nutriment.
Two, on the impact that infant intelligence is grown
1, inspection target: big-movement scoring, fine movement scoring, adaptive capacity scoring, language and Social behaviors, hand eye coordination scoring, operation show scoring.
2, research object: select 210 infants as research object, research object is divided into seven groups at random:
Group 1-group 5 feeds the infant formula goat milk powder that embodiment 1-5 adds gangliosides, as test group 1-5;
Group 6 feeds the formula milk that obtains of comparative examples, and as a control group 2;
Group 7 feeds breast milk, as breast milk group.
Research object age, sex, childbirth options, maternal age, mother's health status, the equilibrium of family income situation equal distribution between each group, there was no significant difference (P>0.05).Concrete test method is: select the baby at about 6 monthly ages to test its mental capacity first, all babies are on close level in the intelligence development at 6 monthly ages; Again carry out mental capacity test when the 12nd monthly age, test data refers to table 3.
3, result of the test:
The impact that control group 2, test group 1-5 and breast milk group are grown infant intelligence is as table 3:
The baby of table 3 control group 2, test group 1-5 and breast milk group is at the intelligence development statistical form at 12 monthly ages
As can be seen from Table 3, the intelligence development mark of test group 1-5 baby is apparently higher than the intelligence development mark of control group 2, and close with the intelligence development mark of breast milk group (specifically: in fine movement, language and Social behaviors, hand eye coordination, big-movement, adaptive capacity and operate the mark showed equal convergence breast milk group or identical with breast milk group).
In sum, adding of gangliosides makes infant formula goat milk powder of the present invention more close to breast milk, is of value to the brain development (being embodied in intelligence development aspect) of infant.
The foregoing is only the preferred embodiments of the present invention, be not limited to the present invention, for a person skilled in the art, the present invention can have various modifications and variations.Within the spirit and principles in the present invention all, any amendment done, equivalent replacement, improvement etc., all should be included within protection scope of the present invention.
Claims (8)
1. an infant formula goat milk powder, is characterized in that, comprises following component with weight parts raw material:
2. infant formula goat milk powder according to claim 1, is characterized in that, described compound probiotic is made up of the animal bifidobacteria of 1:0.5-1.5 weight proportion and lactobacillus acidophilus.
3. the infant formula goat milk powder according to claim 1-2 any one, is characterized in that, described vegetable oil by weight proportion be the coconut oil of 3:2:1, soybean oil and sunflower oil form; Vitamin premix by weight proportion is: the ascorbic acid of 65:7:5:2.4:1:0.7:0.65:0.53:0.78:0.04:0.02:0.01:0.01:6.65: 37.2, dl-α-D-α-tocopherol acetate, niacinamide, D-VB5 calcium, riboflavin, thiamine hydrochloride, puridoxine hydrochloride, axerophtholum aceticum, folic acid, phytondione, biotin, Vitamin D3, cyanocobalamin, Choline Chloride and inositol form; Described material premix by weight proportion be the calcium carbonate of 33:15:16:11:5:3.2:0.4:0.25:0.04:0.015:0.009:0.001, natrium citricum, calcium monohydrogen phosphate, calcium chloride, potassium citrate, magnesium chloride, ferrous sulfate, zinc sulfate, copper sulphate, manganese sulfate, KI and sodium selenite form.
4. infant formula goat milk powder according to claim 3, is characterized in that, comprises following component with weight parts raw material:
5. infant formula goat milk powder according to claim 3, is characterized in that, comprises following component with weight parts raw material:
6. infant formula goat milk powder according to claim 3, is characterized in that, comprises following component with weight parts raw material:
7. a preparation method for the infant formula goat milk powder as described in claim 1-6 any one, is characterized in that, comprises the following steps:
Step one: premixed, be specially: the degreasing goat milk powder of predetermined weight proportioning, concentrated sheep PURE WHEY, vegetable oil, OPO Structure grease, glucose syrup solids, lactose and water are mixed and obtains the first batching, put into temporary storage tank to keep in, temporary storage time is no more than 12 hours, and wherein the weight of water is degreasing goat milk powder, concentrates 2.0-4.0 times of sheep PURE WHEY, vegetable oil, OPO Structure grease, glucose syrup solids and lactose six kinds of material gross weights;
Step 2: homogeneous for the first time, is specially: the first batching step one obtained is carried out homogeneous and obtained the second batching in high pressure homogenizer, and homogenization pressure is 12-18Mpa;
Step 3: first time sterilization, is specially: prepared burden by step 2 gained second and carry out sterilization in tubular type sterilizer, sterilization temperature is 90-100 DEG C, and sterilizing time is 1-2min;
Step 4: concentrated, is specially: being prepared burden by second after step 3 sterilization to carry out concentrating in triple effect evaporator obtains the 3rd batching;
Step 5: second time sterilization, is specially: the 3rd batching is carried out sterilization in tubular type sterilizer, and sterilization temperature is 70-75 DEG C, and sterilizing time is 1-5min;
Step 6: second time homogeneous, is specially: the 3rd batching after step 5 sterilization is carried out homogeneous in homogenizer and obtains the 4th batching, homogenization pressure is 12-18Mpa;
Step 7: dry, is specially: the spray-dried tower of the 4th batching is carried out spraying dry, obtains the 5th batching;
Step 8: be dry mixed, is specially: the full-cream goat milk powder of predetermined weight proportioning, FOS, galactooligosaccharide, DHA, arachidonic acid, vitamin premix, mineral substance premix, nucleotides, l-cn, butterfat and compound probiotic, taurine and gangliosides are added in the 5th batching and carry out mixing and obtaining infant formula goat milk powder.
8. the preparation method of infant formula goat milk powder according to claim 7, is characterized in that, described first time homogenizing process and second time homogenizing process in homogenization pressure be 15Mpa;
In described first time sterilization process: sterilization temperature is 95 DEG C, and sterilizing time is 1min;
In described second time sterilization process: sterilization temperature is 72 DEG C, sterilizing time is 1min.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510944240.1A CN105558059A (en) | 2015-12-16 | 2015-12-16 | Formula goat milk powder for infants and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510944240.1A CN105558059A (en) | 2015-12-16 | 2015-12-16 | Formula goat milk powder for infants and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105558059A true CN105558059A (en) | 2016-05-11 |
Family
ID=55869180
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510944240.1A Pending CN105558059A (en) | 2015-12-16 | 2015-12-16 | Formula goat milk powder for infants and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105558059A (en) |
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105994680A (en) * | 2016-05-16 | 2016-10-12 | 北安宜品努卡乳业有限公司 | Infant formula goat milk powder and preparation method thereof |
| CN106259938A (en) * | 2015-06-01 | 2017-01-04 | 内蒙古伊利实业集团股份有限公司 | Breast milk 0-12 month babies ' formula milk powder containing nucleotide and OPO structured lipid and preparation method thereof |
| CN106578092A (en) * | 2016-12-21 | 2017-04-26 | 海普诺凯营养品有限公司 | Children milk powder and making method thereof |
| CN109105495A (en) * | 2018-08-15 | 2019-01-01 | 西安安诺乳业有限公司 | Baby formula milk powder and preparation method thereof containing choline chloride and L-carnitine |
| CN109122902A (en) * | 2018-08-15 | 2019-01-04 | 西安安诺乳业有限公司 | A kind of baby formula milk powder and preparation method thereof containing lutein |
| CN109221443A (en) * | 2018-08-15 | 2019-01-18 | 西安安诺乳业有限公司 | A kind of baby formula milk powder and preparation method thereof containing inositol and taurine |
| CN110074190A (en) * | 2019-05-28 | 2019-08-02 | 黑龙江贝特佳营养食品有限公司 | A kind of infant formula goat milk powder produced with degreasing goat milk powder |
| EP3826476A4 (en) * | 2018-07-24 | 2022-05-04 | ATR Thrive, LLC | Compositions of lipases and pregastric esterases for mammalia nutrition support |
| CN114668049A (en) * | 2020-12-24 | 2022-06-28 | 蓝河营养品有限公司 | Infant formula sheep milk powder added with functional ingredients simulating breast milk |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101449708A (en) * | 2008-12-29 | 2009-06-10 | 山东龙力生物科技有限公司 | Infant milk powder added with biostime and preparation method thereof |
| CN101484024A (en) * | 2006-06-30 | 2009-07-15 | 艾博特公司 | Enriched infant formulas |
| CN104996576A (en) * | 2015-08-28 | 2015-10-28 | 海普诺凯营养品有限公司 | Goat milk powder for infant and preparation method thereof |
| CN105053217A (en) * | 2015-09-14 | 2015-11-18 | 海普诺凯营养品有限公司 | Infant formula ewe milk powder and production method thereof |
-
2015
- 2015-12-16 CN CN201510944240.1A patent/CN105558059A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101484024A (en) * | 2006-06-30 | 2009-07-15 | 艾博特公司 | Enriched infant formulas |
| CN101449708A (en) * | 2008-12-29 | 2009-06-10 | 山东龙力生物科技有限公司 | Infant milk powder added with biostime and preparation method thereof |
| CN104996576A (en) * | 2015-08-28 | 2015-10-28 | 海普诺凯营养品有限公司 | Goat milk powder for infant and preparation method thereof |
| CN105053217A (en) * | 2015-09-14 | 2015-11-18 | 海普诺凯营养品有限公司 | Infant formula ewe milk powder and production method thereof |
Cited By (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106259938A (en) * | 2015-06-01 | 2017-01-04 | 内蒙古伊利实业集团股份有限公司 | Breast milk 0-12 month babies ' formula milk powder containing nucleotide and OPO structured lipid and preparation method thereof |
| CN106259938B (en) * | 2015-06-01 | 2019-01-18 | 内蒙古伊利实业集团股份有限公司 | Breast milk 0-12 month babies ' formula milk powder and preparation method thereof containing nucleotide and OPO structured lipid |
| CN105994680A (en) * | 2016-05-16 | 2016-10-12 | 北安宜品努卡乳业有限公司 | Infant formula goat milk powder and preparation method thereof |
| CN106578092A (en) * | 2016-12-21 | 2017-04-26 | 海普诺凯营养品有限公司 | Children milk powder and making method thereof |
| EP3826476A4 (en) * | 2018-07-24 | 2022-05-04 | ATR Thrive, LLC | Compositions of lipases and pregastric esterases for mammalia nutrition support |
| CN109105495A (en) * | 2018-08-15 | 2019-01-01 | 西安安诺乳业有限公司 | Baby formula milk powder and preparation method thereof containing choline chloride and L-carnitine |
| CN109122902A (en) * | 2018-08-15 | 2019-01-04 | 西安安诺乳业有限公司 | A kind of baby formula milk powder and preparation method thereof containing lutein |
| CN109221443A (en) * | 2018-08-15 | 2019-01-18 | 西安安诺乳业有限公司 | A kind of baby formula milk powder and preparation method thereof containing inositol and taurine |
| CN110074190A (en) * | 2019-05-28 | 2019-08-02 | 黑龙江贝特佳营养食品有限公司 | A kind of infant formula goat milk powder produced with degreasing goat milk powder |
| CN114668049A (en) * | 2020-12-24 | 2022-06-28 | 蓝河营养品有限公司 | Infant formula sheep milk powder added with functional ingredients simulating breast milk |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105558059A (en) | Formula goat milk powder for infants and preparation method thereof | |
| CN101233873B (en) | Liquid state milk suitable for baby from newborn to six months old | |
| CN108029768A (en) | A kind of baby formula milk powder containing lactoferrin and probiotics and preparation method thereof | |
| CN103564044B (en) | A kind of Yoghourt containing marine alga and preparation method thereof | |
| CN102524421B (en) | Novel acid-base balance infant formula milk powder and preparation method thereof | |
| CN101427787A (en) | Liquid milk with additive arachidonic acid suitable for baby of 12 to 36 months old | |
| CN102422900A (en) | Formula milk powder for promoting absorption of fatty acid and calcium and preparation method thereof | |
| CN105746728A (en) | Infant formula milk powder simulating breast milk and preparation method of infant formula milk powder | |
| CN104996576A (en) | Goat milk powder for infant and preparation method thereof | |
| CN105532883A (en) | Formula goat milk powder for infants and young children and preparation method thereof | |
| CN105053217A (en) | Infant formula ewe milk powder and production method thereof | |
| CN106578092A (en) | Children milk powder and making method thereof | |
| CN107712050A (en) | One kind addition sialic acid and digestible premature labor baby milk powder and preparation method thereof | |
| CN101869151B (en) | Baby milk powder comprising lactadherin and preparation method thereof | |
| CN103070241A (en) | Infant-formula goat milk powder of pure goat milk protein and preparation method thereof | |
| CN106605709B (en) | Liquid milk suitable for children of 3-6 years old and preparation method thereof | |
| CN101946826A (en) | Formula milk for baby and children with food preference and production method thereof | |
| CN111264623A (en) | Milk powder for promoting growth and development of children and preparation method thereof | |
| CN103070242A (en) | Formula goat milk powder for pregnant women and preparation method of formula goat milk powder | |
| CN103039605A (en) | Pregnant woman milk powder capable of restraining early pregnancy reaction and preparation method thereof | |
| CN106912614A (en) | A kind of humanized formula milk and preparation method thereof | |
| CN109077123A (en) | A kind of infant formula goat milk powder produced using concentrating and desalinating sheep whey liquid | |
| CN101584364B (en) | Liquid milk product containing fructus alpiniae oxyphyllae factor combination and preparation method thereof | |
| CN106212723A (en) | A kind of babies ' formula milk powder and preparation method thereof | |
| CN105076418A (en) | Infant formula milk powder for promoting development of brain nerves and gastrointestinal tissues of infants |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160511 |